Analgesics Market in Sweden to 2014 (OTC Healthcare)

Introduction

Analgesics Market in Sweden to 2014 (OTC Healthcare) is a comprehensive resource for market and segment level data on value from 2004 to 2014 and market/company shares for 2008-09.This report also provides data on key distribution channels and reveals the leading companies in the Swedish analgesics market.

Features and Benefits

• Identify key market segments by analyzing market size data on value for categories
• Design business strategies by gaining insight into quantitative market trends over 2004-09 and expectations for 2010-14
• Identify key companies in the analgesics market in Sweden and design M&A strategies by analyzing market share data


Highlights

•The analgesics market in Sweden increased at a compound annual growth rate of 5.4% between 2004 and 2009.
• The paracetamol category led the analgesics market in Sweden in 2009, with a share of 42.4%.
•Leading player in analgesics market in Sweden is Johnson & Johnson.


Key questions answered

• Which will be the fastest growing segment within the analgesics market in Sweden?
• How will the forecast growth differ from the historic growth exhibited by the analgesics market in Sweden?
• Which company accounted for the largest share of the Swedish analgesics market in 2009?

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary category level: analgesics 2
Chapter 2 Definition 3
Chapter 3 Category Analysis: Analgesics 8
Value analysis (Swedish Krona), 2004?09 8
Value analysis (Swedish Krona), 2009?14 9
Value analysis (US dollars), 2004?09 11
Value analysis (US dollars), 2009?14 11
Company and brand share analysis 13
Distribution analysis 16
Chapter 4 Macroeconomic Profile 18
Macroeconomic Indicators 18
Chapter 5 Research Methodology 23
Methodology overview 23
Secondary research 24
Market modeling 25
Creating an initial data model 25
Revising the initial data model 25
Creating a final estimate 26
Creating demographic value splits 26
Primary research 26
Data finalization 27
Ongoing research 27

LIST OF FIGURES
Figure 1: Analgesics, Sweden, value by segment (SEKm), 2004?14 10
Figure 2: Analgesics, Sweden, category growth comparison, by value, 2004?14 12
Figure 3: Analgesics, Sweden, company share by value (%), 2008?09 14
Figure 4: Analgesics, Sweden, distribution channels by value (%), 2008?09 17
Figure 5: Annual data review process 24

LIST OF TABLES
Table 1: Analgesics category definitions 3
Table 2: Analgesics distribution channels 4
Table 3: Analgesics, Sweden, value by segment (SEKm), 2004?09 8
Table 4: Analgesics, Sweden, value forecast by segment (SEKm), 2009?14 9
Table 5: Analgesics, Sweden, value by segment ($m), 2004?09 11
Table 6: Analgesics, Sweden, value forecast by segment ($m), 2009?14 11
Table 7: Analgesics, Sweden, brand share by value (%), 2008?09 13
Table 8: Analgesics, Sweden, value by brand (SEKm), 2008?09 13
Table 9: Analgesics, Sweden, company share by value (%), 2008?09 15
Table 10: Analgesics, Sweden, value by company (SEKm), 2008?09 15
Table 11: Analgesics, Sweden, distribution channels by value (%), 2008?09 16
Table 12: Analgesics, Sweden, value by distribution channel (SEKm), 2008?09 16
Table 13: Sweden population, by age group, 2004?09 (millions) 18
Table 14: Sweden population forecast, by age group, 2009?14 (millions) 19
Table 15: Sweden population, by gender, 2004?09 (millions) 19
Table 16: Sweden population forecast, by gender, 2009?14 (millions) 20
Table 17: Sweden nominal GDP, 2004?09 (SEKbn, nominal prices) 20
Table 18: Sweden nominal GDP forecast, 2009?14 (SEKbn, nominal prices) 20
Table 19: Sweden real GDP, 2004?09 (SEKbn, 2000 prices) 21
Table 20: Sweden real GDP forecast, 2009?14 (SEKbn, 2000 prices) 21
Table 21: Sweden real GDP, 2004?09 ($bn, 2000 prices) 21
Table 22: Sweden real GDP forecast, 2009?14 ($bn, 2000 prices) 22
Table 23: Sweden consumer price index, 2004?09 (2000=100) 22
Table 24: Sweden consumer price index, 2009?14 (2000=100) 22


[Inhaltsverzeichnis ausblenden]